Decision to Extend KRW 4.37 Billion Loan to Subsidiary UTI VINA

Decision to extend a USD 3 million (approx. KRW 4.37 billion) loan to subsidiary UTI VINA at 4.6% interest for 3 years
Loan purpose: facility and operating funds; extension of existing loan from 2023
As of end-2025, UTI VINA had negative equity of -KRW 12.87 billion and net loss of KRW 17.19 billion, indicating weak financial health
Loan amount represents 6.6% of parent's equity (KRW 65.82 billion); total outstanding loans to this subsidiary amount to KRW 38.605 billion